These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 23168523

  • 1. Reductions in glucose among postmenopausal women who use and do not use estrogen therapy.
    Kim C, Kong S, Laughlin GA, Golden SH, Mather KJ, Nan B, Randolph JF, Edelstein SL, Labrie F, Buschur E, Barrett-Connor E, Diabetes Prevention Program Research Group.
    Menopause; 2013 Apr; 20(4):393-400. PubMed ID: 23168523
    [Abstract] [Full Text] [Related]

  • 2. The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program.
    Golden SH, Kim C, Barrett-Connor E, Nan B, Kong S, Goldberg R, Diabetes Prevention Program Research Group.
    Metabolism; 2013 Sep; 62(9):1313-22. PubMed ID: 23660512
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Does hormone therapy affect blood pressure changes in the Diabetes Prevention Program?
    Kim C, Golden SH, Kong S, Nan B, Mather KJ, Barrett-Connor E, Diabetes Prevention Program Research Group.
    Menopause; 2014 May; 21(5):477-83. PubMed ID: 23942251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Weight loss increases follicle stimulating hormone in overweight postmenopausal women [corrected].
    Kim C, Randolph JF, Golden SH, Labrie F, Kong S, Nan B, Barrett-Connor E.
    Obesity (Silver Spring); 2015 Jan; 23(1):228-33. PubMed ID: 25294746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in Visceral Adiposity, Subcutaneous Adiposity, and Sex Hormones in the Diabetes Prevention Program.
    Kim C, Dabelea D, Kalyani RR, Christophi CA, Bray GA, Pi-Sunyer X, Darwin CH, Yalamanchi S, Barrett-Connor E, Golden SH, Boyko EJ.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3381-3389. PubMed ID: 28651370
    [Abstract] [Full Text] [Related]

  • 11. Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women.
    Karim R, Mack WJ, Hodis HN, Roy S, Stanczyk FZ.
    J Clin Endocrinol Metab; 2009 Nov 01; 94(11):4136-43. PubMed ID: 19808850
    [Abstract] [Full Text] [Related]

  • 12. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R, Vicennati V, Bertazzo D, Casimirri F, Pascal G, Tortelli O, Labate AM.
    Metabolism; 1997 Jan 01; 46(1):5-9. PubMed ID: 9005961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar 01; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study.
    Goodman-Gruen D, Barrett-Connor E.
    Diabetes Care; 1997 Apr 01; 20(4):645-9. PubMed ID: 9096996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E, Heart and Estrogen/progestin Replacement Study.
    Ann Intern Med; 2003 Jan 07; 138(1):1-9. PubMed ID: 12513038
    [Abstract] [Full Text] [Related]

  • 19. Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.
    Mather KJ, Kim C, Christophi CA, Aroda VR, Knowler WC, Edelstein SE, Florez JC, Labrie F, Kahn SE, Goldberg RB, Barrett-Connor E, Diabetes Prevention Program.
    J Clin Endocrinol Metab; 2015 Oct 07; 100(10):3778-86. PubMed ID: 26200237
    [Abstract] [Full Text] [Related]

  • 20. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels.
    Nachtigall LE, Raju U, Banerjee S, Wan L, Levitz M.
    Menopause; 2000 Oct 07; 7(4):243-50. PubMed ID: 10914617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.